60
Beijing Tiantan Biological Products Co., Ltd.
600161.SS · SHH
¥12.60 +3.96% (+¥0.48)
1M +2.78%
Market Cap ¥24.9B
P/E Ratio 32.90x
Div. Yield 1.19%
ROE 6.44%
Bulios Fair Price
¥7.01
44.4% downside
Current Price
¥12.6
Undervalued Fair Value Overvalued
According to Bulios Fair Price, 600161.SS is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
5/9Valuation
33 /100
Expensive P/E 32.90x
EV/EBITDA 13.85x
P/FCF 106.04x
Growth
48 /100
Stable EPS growth 9.01%
Rev. growth 12.94%
Book val. growth 10.09%
Profitability
68 /100
Strong Gross margin 38.02%
Net margin 13.50%
FCF margin 4.19%
Quality
32 /100
Poor ROIC 6.34%
ROE 6.44%
Asset turnover 0.33x
Debt
100 /100
Low Debt/Equity 0.01x
Current ratio 6.98x
Net debt/EBITDA -1.21x
Stability
58 /100
Moderate Beta 0.18x
Rev. volatility 10.27%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about 600161.SS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Hui Chuan Yang
Employees
5,205
Headquarters
Beijing
Upcoming events
30 OCT
Earnings
Upcoming earnings report